⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 1, 2010British Journal of CancerOpen Access

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis

View Full Paper

Ask AI

Bookmark

Share

Authors

RZRuth ZárateUniversidad de Oviedo JRJavier RodríguezHospital Universitario de Gran Canaria Doctor Negrín EBEva BandrésNavarre Institute of Health Research

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zárate et al. (2010) studied this question.

synapsesocial.com/papers/6ab31d562b96d91bacb3974e https://doi.org/10.1038/sj.bjc.6605595

View Full Paper

Ask AI

Bookmark

Share